Hamer M, Chida Y
Department of Epidemiology and Public Health, University College London, London, UK.
Br J Sports Med. 2008 Apr;42(4):238-43. doi: 10.1136/bjsm.2007.039974. Epub 2007 Nov 29.
To quantify the association between walking and the risk of cardiovascular disease (CVD) and all-cause mortality in healthy men and women.
Medline, Cochrane Database of Systematic Reviews, and Web of Science databases were searched to May 2007.
Prospective epidemiological studies of walking and CVD and all-cause mortality.
18 prospective studies were included in the overall analysis, which incorporated 459 833 participants free from CVD at baseline with 19 249 cases at follow-up. From the meta-analysis the pooled hazard ratio of CVD in the highest walking category compared with the lowest was 0.69, (95% CI 0.61 to 0.77, p<0.001), and 0.68 (0.59 to 0.78, p<0.001) for all-cause mortality. These effects were robust among men and women, although there was evidence of publication biases for the associations with CVD risk. Walking pace was a stronger independent predictor of overall risk compared with walking volume (48% versus 26% risk reductions, respectively). There was also evidence of a dose-response relationship across the highest, intermediate, and lowest walking categories in relation to the outcome measures.
The results suggest walking is inversely associated with clinical disease endpoints and largely support the current guidelines for physical activity. The mechanisms that mediate this relationship remain largely unknown and should be the focus of future research.
量化健康男性和女性中步行与心血管疾病(CVD)风险及全因死亡率之间的关联。
检索了截至2007年5月的Medline、Cochrane系统评价数据库和科学网数据库。
关于步行与CVD及全因死亡率的前瞻性流行病学研究。
总体分析纳入了18项前瞻性研究,这些研究纳入了459833名基线时无CVD的参与者,随访时有19249例病例。荟萃分析显示,与最低步行类别相比,最高步行类别的CVD合并风险比为0.69(95%CI 0.61至0.77,p<0.001),全因死亡率的合并风险比为0.68(0.59至0.78,p<0.001)。尽管有证据表明与CVD风险的关联存在发表偏倚,但这些效应在男性和女性中都很显著。与步行量相比,步行速度是总体风险更强的独立预测因素(风险降低分别为48%和26%)。在最高、中等和最低步行类别与结局指标之间也存在剂量反应关系的证据。
结果表明步行与临床疾病终点呈负相关,在很大程度上支持当前的身体活动指南。介导这种关系的机制在很大程度上仍然未知,应成为未来研究的重点。